XML 102 R48.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Summary of Stock Options Outstanding and Exercised Under Prior and Existing Stock Incentive Plans
The following is a summary of stock options outstanding and exercised under prior and existing stock incentive plans of the Company:
 
                                 
Year Ended December 31   Stock
Options/Shares
       Weighted-
Average
Exercise Price
      
Weighted-Average

Remaining
Contractual Term
       Aggregate
Intrinsic Value
(in millions)
 
         
2019
                                        
Number outstanding at beginning of period
    9,115,010        $ 34.52                        
Granted
(a)
                                    
Exercised
    (3,333,467        26.36                        
Cancelled
(b)
    (63,287        36.74                        
   
 
 
 
Number outstanding at end of period
(c)
    5,718,256        $ 39.25          4.4        $ 115  
Exercisable at end of period
    4,869,805        $ 37.67          4.0        $ 105  
         
2018
                                        
Number outstanding at beginning of period
    12,668,467        $ 32.15                        
Granted
(a)
                                    
Exercised
    (3,443,494        25.41                        
Cancelled
(b)
    (109,963        46.72                        
   
 
 
 
Number outstanding at end of period
(c)
    9,115,010        $ 34.52          4.3        $ 102  
Exercisable at end of period
    7,372,036        $ 31.61          3.5        $ 104  
         
2017
                                        
Number outstanding at beginning of period
    17,059,241        $ 29.95                        
Granted
    1,066,188          54.97                        
Exercised
    (5,389,741        29.58                        
Cancelled
(b)
    (67,221        43.31                        
   
 
 
 
Number outstanding at end of period
(c)
    12,668,467        $ 32.15          4.5        $ 272  
Exercisable at end of period
    9,647,937        $ 27.87          3.3        $ 248  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a)
The Company did not grant any stock option awards during 2019 and 2018.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b)
Options cancelled include both
non-vested
(i.e., forfeitures) and vested options.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c)
Outstanding options include stock-based awards that may be forfeited in future periods. The impact of the estimated forfeitures is reflected in compensation expense.
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-Average Estimated Fair Value of Stock Options Granted and Assumptions Utilized by Company for Newly Issued Grants The following table includes the weighted-average estimated fair value of stock options granted and the assumptions utilized by the Company for newly issued grants for the year ended December 31, 2017:
         
 
 
 
 
Year Ended December 31   2017  
Estimated fair value
  $ 14.66  
Risk-free interest rates
    2.0
Dividend yield
    2.6
Stock volatility factor
    .35  
Expected life of options (in years)
    5.5  
 
 
 
 
 
 
 
 
Summary of Certain Stock Option Activity
 
 
The following summarizes certain stock option activity of the Company:
 
                         
Year Ended December 31 (Dollars in Millions)   2019        2018        2017  
Fair value of options vested
  $ 10        $ 14        $ 13  
Intrinsic value of options exercised
    95          97          127  
Cash received from options exercised
    88          87          159  
Tax benefit realized from options exercised
   
24
        
24
         49  
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock Options Outstanding Additional Information
Additional information regarding stock options outstanding as of December 31, 2019, is as follows:
 
                                         
    Outstanding Options        Exercisable Options  
Range of Exercise Prices   Shares        Weighted-
Average
Remaining
Contractual
Life (Years)
       Weighted-
Average
Exercise
Price
       Shares        Weighted-
Average
Exercise
Price
 
$23.36—$25.00
    236,661          .2       
$
23.82          236,661       
$
23.82  
$25.01—$30.00
    1,277,726          1.8          28.65          1,277,726          28.65  
$30.01—$35.00
    537,881          3.1          33.98          537,881          33.98  
$35.01—$40.00
    1,251,397          6.1          39.49          885,968          39.49  
$40.01—$45.00
    1,454,651          4.7          42.42          1,454,068          42.43  
$45.01—$50.00
                                         
$50.01—$55.01
    959,940          7.1          54.97          477,501          54.97  
 
    5,718,256          4.4        $ 39.25          4,869,805        $ 37.67  
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Company's Restricted Shares of Stock and Unit Awards
A summary of the status of the Company’s restricted shares of stock and unit awards is presented below:
 
                                                 
    2019      2018      2017  
Year Ended December 31   Shares     
Weighted-
Average Grant-
Date Fair
Value
     Shares     
Weighted-
Average Grant-
Date Fair
Value
     Shares     
Weighted-
Average Grant-
Date Fair
Value
 
Outstanding at beginning of period
    6,719,298      $ 48.17        7,446,955      $ 44.49        8,265,507      $ 39.50  
Granted
    3,519,474        50.45        3,213,023        55.03        2,850,927        54.45  
Vested
    (3,270,778      48.69        (3,373,323      46.42        (3,295,376      40.66  
Cancelled
    (361,161      50.55        (567,357      49.07        (374,103      43.91  
Outstanding at end of period
    6,606,833      $ 48.99        6,719,298      $ 48.17        7,446,955      $ 44.49